Behrooz Sharifi, PhD
No patient rating & comments.
Why?
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
No patient rating & comments.
Why?
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
Behrooz Sharifi, PhD
Los Angeles
127 S San Vicente Blvd #A9100
Los Angeles, CA
34.0746919 -118.3789723From You
No patient rating & comments.
Why?
- The doctor practices in an office or specialty that we currently do not survey.
- The doctor has not yet received the minimum number of patient satisfaction surveys (30) to be eligible for display.
Behrooz Sharifi, PhD
Languages
- English,
Gender
Male
Locations
Experience
Programs
Research Areas
Territorial differences in the propensity of various arterial beds are known to be responsible for the pathophysiology of vascular diseases. Behrooz Sharifi, PhD, has used cell and molecular biology techniques as well as animal models to investigate the role of blood vessel wall-specific genes in the pathophysiology of atherosclerosis, vein graft stenosis and restenosis after balloon angioplasty.
Achievements
-
5
Awards and Honors
-
6
Publications
Awards and Honors
- Panel Member, National Science Foundation
- Phillip and Dorothy Lyons Chair in Molecular Cardiology
- Elected Fellow of the Arteriosclerosis, Thrombosis, Vascular Biology Council
- Charter Member, NIH Study section
- Established Investigator Award
Publications
A full list of this provider’s research publications can be found on their research profile or PubMed.
- Wang L, Sharifi BG, Pan T, Song L, Yukht A, Shah PK. Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice. J Am Coll Cardiol. 2006 Oct 3;48(7):1459-1468.
- Wallner K, Li C, Shah PK, Wu KJ, Schwartz SM, Sharifi BG. EGF-Like domain of tenascin-C is proapoptotic for cultured smooth muscle cells. Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1416-1421.
- Sharifi BG, Zeng Z, Wang L, Song L, Chen H, Qin M, Sierra-Honigmann MR, Wachsmann-Hogiu S, Shah PK. Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells. Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1273-1280.
- Qin M, Zeng Z, Zheng J, Shah PK, Schwartz SM, Adams LD, Sharifi BG. Suppression subtractive hybridization identifies distinctive expression markers for coronary and internal mammary arteries. Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):425-433.
- LaFleur DW, Fagin JA, Forrester JS, Rubin SA, Sharifi BG. Cloning and characterization of alternatively spliced isoforms of rat tenascin. Platelet-derived growth factor-BB markedly stimulates expression of spliced variants of tenascin mRNA in arterial smooth muscle cells. J Biol Chem. 1994 Aug 12;269(32):20757-20763.
- LaFleur DW, Chiang J, Fagin JA, Schwartz SM, Shah PK, Wallner K, Forrester JS, Sharifi BG. Aortic smooth muscle cells interact with tenascin-C through its fibrinogen-like domain. J Biol Chem. 1997 Dec 26;272(52):32798-32803.